Showing results (21-30 of 110) with videos related to
Sort By:
Pageof 11
European Journal of Histochemistry : EJH|November 2, 2020
Different iron-handling in inflamed small and large cholangiocytes and in small and large-duct type intrahepatic cholangiocarcinomaRomina Mancinelli, Antimo Cutone, Luigi Rosa, et al.Journal of Ethnopharmacology|September 19, 2009
Chelidonium majus is not hepatotoxic in Wistar rats, in a 4 weeks feeding experimentGabriela Mazzanti, Antonella Di Sotto, Antonio Franchitto, et al.Life (Basel, Switzerland)|December 23, 2022
The Emerging Role of Ferroptosis in Liver CancersArianna Casini, Stefano Leone, Rosa Vaccaro, et al.European Journal of Histochemistry : EJH|October 20, 2023
Expression and role of cocaine-amphetamine regulated transcript (CART) in the proliferation of biliary epitheliumArianna Casini, Giorgio Vivacqua, Rosa Vaccaro, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|December 22, 2007
Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activationSharon DeMorrow, Heather Francis, Eugenio Gaudio, et al.Experimental Biology and Medicine (Maywood, N.J.)|February 24, 2009
Taurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expressionRomina Mancinelli, Paolo Onori, Eugenio Gaudio, et al.The Journal of Pediatrics|December 5, 2017
Laparoscopic Sleeve Gastrectomy Improves Nonalcoholic Fatty Liver Disease-Related Liver Damage in Adolescents by Reshaping Cellular Interactions and Hepatic Adipocytokine ProductionValerio Nobili, Guido Carpino, Francesco De Peppo, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 2007
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathwayHeather Francis, Antonio Franchitto, Yoshiyuki Ueno, et al.Journal of Pineal Research|February 16, 2020
Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapiesKeisaku Sato, Fanyin Meng, Heather Francis, et al.International Journal of Cancer|November 12, 2009
Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptorPaolo Onori, Candace Wise, Eugenio Gaudio, et al.Pageof 11